Cantor Fitzgerald Starts VolitionRX (VNRX) at Overweight
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
VolitionRx Limited to Present at Conferences in March 2021
March 8, 2021 4:15 PM ESTAUSTIN, Texas, March 8, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that its Chief Executive Officer, Cameron Reynolds, and its Executive Vice President, Investor Relations, Scott Powell, are scheduled to present at six conferences in March 2021.
During the conferences, Mr. Reynolds and Dr. Powell will outline Volition's business, clinical, regulatory and operational milestones.
Details of the conference presentations (all virtual) are as follows:
H.C. Wainwright Global Life Sciences Conference - March 9-10, 2021Presentation: Tuesday March 9 at 7:00 am ETRegister:... More
